Agios Pharmaceuticals saw the highest growth of 199% in patent filings and 128% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 199% and grants by 128%. GlobalData’s DataBook provides a comprehensive analysis of Agios Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Agios Pharmaceuticals has been focused on protecting inventions in United States(US) with five publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 11% filings and 21% grants. The South Korea(KR), Hungary(HU), United States(US), and Spain(ES) patent Office are among the top ten patent offices where Agios Pharmaceuticals is filings its patents. Among the top granted patent authorities, Agios Pharmaceuticals has 21% of its grants in United States(US), 11% in Spain(ES) and 11% in Moldova(MD).

F. Hoffmann-La Roche and Bristol-Myers Squibb could be the strongest competitors for Agios Pharmaceuticals

Patents related to rare diseases and climate change lead Agios Pharmaceuticals's portfolio

Agios Pharmaceuticals has the highest number of patents in rare diseases followed by, climate change. For rare diseases, nearly 100% of patents were filed and 50% of patents were granted in Q1 2024.

Refining related patents lead Agios Pharmaceuticals portfolio followed by thalassemia, and acquired (autoimmune) hemolytic anemia

Agios Pharmaceuticals has highest number of patents in refining followed by thalassemia, acquired (autoimmune) hemolytic anemia, sickle cell disease, and manufacturing/industrial. For refining, nearly 20% of patents were filed and 12% of patents were granted in Q1 2024.

For comprehensive analysis of Agios Pharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.